. .turn on desktop notifications for breaking stories about interest? . . .: "arise: a phase 3 randomized trial of erenumab for episodic migraine." . .: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies."